info icon

This is a non-core endpoint: only basic statistics are computed.

Use of rivastigmine

ADMED_ACHEI_RIVASTIGMINE

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC N06DA03

1 out of 7 registries used, show all original rules.

4084

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

4084

diagram downward connector

Include endpoints None

4084

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

3965

diagram downward connector
ADMED_ACHEI_RIVASTIGMINE

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 3965 1848 2117
Unadjusted prevalence (%) 0.96 0.80 1.16
Mean age at first event (years) 78.03 78.47 77.64

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: ADMED_ACHEI_RIVASTIGMINE – Use of rivastigmine
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Use of rivastigmine

Endpoint not on priority list, no data to show.